There's no way .06 is a top out if FDA grants human trials and all goes well.......I'd say .06 minimum if this lung tumor is eliminated. FDA/Denovo/Right to Try.....all a new ballgame into the dollars.
Mind you a buyout would be a different scenario on its own as well. Too many upward directions this can take.